SCHEMBL21742996

SCHEMBL21742996

CC1(O)CCC(CS(=O)(=O)c2ccc(Br)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLCG1 P19174 1/20 0.44
CTDSP1 Q9GZU7 2/20 0.41
POLB P06746 2/20 0.41
APP P05067 1/20 0.39
KMT2A Q03164 2/20 0.38
PTGS2 P35354 1/20 0.36
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
MEN1 O00255 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CRBN Q96SW2 1/20 0.36
AOC2 O75106 2/20 0.36
PSEN1 P49768 1/20 0.36
PSEN2 P49810 1/20 0.36
APH1B Q8WW43 1/20 0.36
NCSTN Q92542 1/20 0.36
APH1A Q96BI3 1/20 0.36
PSENEN Q9NZ42 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21742995 1.00 PLCG1 (0.44) PLCG1CTDSP1POLBAPPKMT2A
SCHEMBL21743001 0.83 PSEN1 (0.40) MAOAMAOBCRBNAOC2PSEN1
SCHEMBL21743226 0.83 PSEN1 (0.40) MAOAMAOBCRBNAOC2PSEN1
SCHEMBL21715548 0.82 MMP2 (0.46) PTGS2CRBNPSEN1PSEN2APH1B
SCHEMBL2413925 0.82 PLCG1 (0.59) PLCG1CTDSP1POLBKMT2AMAOA
SCHEMBL21743197 0.80 PSEN1 (0.34) CRBNPSEN1PSEN2APH1BNCSTN
SCHEMBL21742984 0.80 PSEN1 (0.34) CRBNPSEN1PSEN2APH1BNCSTN
SCHEMBL22289434 0.79 PLCG1 (0.55) PLCG1CTDSP1POLBKMT2AMEN1
SCHEMBL21743134 0.78 CA1 (0.43) CA1CA2
SCHEMBL21743133 0.78 CA1 (0.43) CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3837244-B1 1-METHYL-4-[(4-PHENYLPHENYL)SULFONYLMETHYL]CYCLOHEXYANOL AND 1-METHYL-4-[[4-(2-PYRIDYL)PHENYL]SULFONYLMETHYL]CYCLOHEXANOL COMPOUNDS AND THEIR THERAPEUTIC USE ISTESSO THERAPEUTICS LTD (GB) 2025-05-14 EP disclosed
US-12240814-B2 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexyanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylmethyl]cyclohexanol compounds and their therapeutic use ISTESSO THERAPEUTICS LIMITED (GB) 2025-03-04 US disclosed
US-20240182418-A1 1-Methyl-4-[(4-Phenylphenyl)Sulfonylmethyl]Cyclohexyanol And 1-Methyl-4-[[4-(2-Pyridyl)Phenyl]Sulfonylmethyl]Cyclohexanol Compounds and Their Therapeutic Use Modern Biosciences Limited (GB) 2024-06-06 US disclosed
US-11834414-B2 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexyanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylmethyl]cyclohexanol compounds and their therapeutic use Modern Biosciences Limited (GB) 2023-12-05 US disclosed
US-20220363642-A1 1-METHYL-4-[(4-PHENYLPHENYL)SULFONYLMETHYL]CYCLOHEXYANOL AND 1-METHYL-4-[[4-(2-PYRIDYL)PHENYL]SULFONYLMETHYL]CYCLOHEXANOL COMPOUNDS AND THEIR THERAPEUTIC USE ISTESSO THERAPEUTICS LIMITED (GB) 2022-11-17 US disclosed
CN-112805270-A 1-methyl-4- [ (4-phenylphenyl) sulfonylmethyl ] cyclohexanol and 1-methyl-4- [ [4- (2-pyridinyl) phenyl ] sulfonylmethyl ] cyclohexanol compounds and therapeutic uses thereof 现代生物科学有限公司 2021-05-14 CN disclosed
WO-2020035560-A1 1-METHYL-4-[(4-PHENYLPHENYL)SULFONYLMETHYL]CYCLOHEXYANOL AND 1-METHYL-4-[[4-(2-PYRIDYL)PHENYL]SULFONYLMETHYL]CYCLOHEXANOL COMPOUNDS AND THEIR THERAPEUTIC USE Modern Biosciences Limited (GB) 2020-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363642-A1 1-METHYL-4-[(4-PHENYLPHENYL)SULFONYLMETHYL]CYCLOHEXYANOL AND 1-METHYL-4-[[4-(2-PYRIDYL)PHENYL]SULFONYLMETHYL]CYCLOHEXANOL COMPOUNDS AND THEIR THERAPEUTIC USE MALT1, BCL3, MCL1 PLCG1 3424/4885CTDSP1 4115/4885POLB 3740/4885
US-11834414-B2 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexyanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylmethyl]cyclohexanol compounds and their therapeutic use MALT1, BCL3, MCL1 PLCG1 3424/4885CTDSP1 4115/4885POLB 3740/4885
US-12240814-B2 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexyanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylmethyl]cyclohexanol compounds and their therapeutic use MALT1, BCL3, MCL1 PLCG1 3424/4885CTDSP1 4115/4885POLB 3740/4885
US-20240182418-A1 1-Methyl-4-[(4-Phenylphenyl)Sulfonylmethyl]Cyclohexyanol And 1-Methyl-4-[[4-(2-Pyridyl)Phenyl]Sulfonylmethyl]Cyclohexanol Compounds and Their Therapeutic Use MALT1, BCL3, MCL1 PLCG1 3424/4885CTDSP1 4115/4885POLB 3740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.